# Lobbying Reform: Stakeholders

## Who Benefits from the Status Quo

### The Lobbying Industry

**Lobbying Firms**

| Type | Benefit |
|------|---------|
| K Street giants | Billions in revenue |
| Boutique specialists | High margins |
| Law firm lobbying practices | Premium billing |
| Public affairs firms | Integrated services |

**Major Players**

| Firm | Annual Revenue |
|------|----------------|
| Akin Gump | $50+ million |
| Squire Patton Boggs | $45+ million |
| Brownstein Hyatt | $40+ million |
| BGR Group | $35+ million |
| Holland & Knight | $35+ million |

### Corporate Beneficiaries

**Highest-Spending Industries**

| Industry | Annual Spending | Key Wins |
|----------|-----------------|----------|
| Pharmaceuticals | $370+ million | Drug pricing protection |
| Technology | $245+ million | Antitrust avoidance |
| Insurance | $175+ million | ACA negotiations |
| Oil and Gas | $150+ million | Subsidies, permits |
| Finance | $145+ million | Deregulation |

**Specific Corporate Benefits**

| Company Type | Lobbying Return |
|--------------|-----------------|
| Defense contractors | Procurement wins |
| Pharmaceutical | Patent protections |
| Financial institutions | Regulatory relief |
| Energy companies | Subsidies, permits |
| Tech giants | Antitrust avoidance |

### Political Beneficiaries

**Members of Congress**

| Benefit | Mechanism |
|---------|-----------|
| Campaign funds | Lobbyist bundling |
| Reelection support | Industry PACs |
| Future employment | K Street jobs |
| Policy expertise | Lobbyist information |
| Travel and gifts | (Limited but present) |

**Former Officials**

| Position | Post-Government Value |
|----------|----------------------|
| Former members | $500K-2M+ salary |
| Senior staff | 200-300% salary increase |
| Agency heads | Major compensation |
| White House staff | Premium value |

### Consultants and Advisors

**Shadow Lobbying**

| Role | Benefit |
|------|---------|
| Strategic consultants | Influence without disclosure |
| PR firms | Campaign support |
| Think tank affiliates | Legitimacy provision |
| Law firms | Legal + lobbying bundle |

## Who Is Harmed

### The General Public

**Democratic Harm**

| Impact | Effect |
|--------|--------|
| Policy not responsive | Legislation favors donors |
| Voice inequality | Average citizen ignored |
| Trust erosion | Cynicism about government |
| Participation decline | Why bother? |

**Economic Harm**

| Area | Public Cost |
|------|-------------|
| Tax loopholes | Lost revenue ($billions) |
| Consumer protection | Weaker regulations |
| Healthcare costs | Industry-friendly pricing |
| Environmental harm | Weakened standards |

### Under-Resourced Interests

**Disadvantaged Groups**

| Group | Lobbying Capacity |
|-------|-------------------|
| Low-income Americans | Near zero |
| Children | No vote, no money |
| Future generations | Not represented |
| Diffuse consumer interests | Hard to organize |
| Environmental interests | Outspent |

**Resource Gap Examples**

| Issue | Corporate Lobbying | Public Interest |
|-------|-------------------|-----------------|
| Drug pricing | $370M (pharma) | ~$20M (advocates) |
| Climate policy | $100M+ (fossil) | ~$10M (environmental) |
| Financial regulation | $200M+ (Wall Street) | ~$5M (consumer groups) |

### Small Businesses

**Competitive Disadvantage**

| Issue | Effect |
|-------|--------|
| Can't afford lobbyists | Policy favors big business |
| Trade associations | Often captured by large members |
| Regulatory complexity | Compliance burden |
| Tax code complexity | Can't exploit loopholes |

### Public Interest Organizations

**Structural Disadvantages**

| Challenge | Effect |
|-----------|--------|
| Limited resources | Can't match spending |
| Volunteer dependency | Less professionalized |
| Broad mandate | Less specialized |
| Foundation dependence | Funding constraints |

## Who Has Power to Change Things

### Congress

**Key Actors**

| Actor | Power |
|-------|-------|
| Leadership | Control floor agenda |
| Rules committees | Determine procedures |
| Ethics committees | Enforcement (weak) |
| Reform-minded members | Introduce legislation |

**Committees of Jurisdiction**

| Committee | Role |
|-----------|------|
| House Administration | Election/lobbying rules |
| Senate Rules | Procedures |
| Judiciary committees | Ethics laws |
| Appropriations | Enforcement funding |

### Executive Branch

**Presidential Powers**

| Tool | Application |
|------|-------------|
| Executive orders | Revolving door rules |
| Appointments | Enforcement officials |
| Regulatory guidance | Disclosure requirements |
| Bully pulpit | Public attention |

**Key Agencies**

| Agency | Role |
|--------|------|
| DOJ | Criminal enforcement |
| Office of Government Ethics | Executive ethics |
| White House Counsel | Administration standards |

### Courts

**Judicial Role**

| Function | Effect |
|----------|--------|
| Constitutional review | First Amendment limits |
| Statutory interpretation | Define lobbying |
| Enforcement support | Criminal prosecutions |
| Precedent setting | Citizens United impact |

### Civil Society

**Reform Organizations**

| Organization | Role |
|--------------|------|
| Issue One | Bipartisan reform advocacy |
| Represent.Us | Anti-corruption campaigns |
| Common Cause | Democracy reform |
| Public Citizen | Watchdog |
| CREW | Ethics enforcement |

**Media**

| Role | Potential |
|------|-----------|
| Investigative journalism | Expose corruption |
| Public education | Explain system |
| Accountability | Name and shame |

## Potential Allies

### Bipartisan Reform Coalition

**Conservative Reformers**

| Motivation | Examples |
|------------|----------|
| Anti-cronyism | Free market conservatives |
| Drain the swamp | Populist right |
| Small government | Skeptical of lobbying |
| Religious values | Anti-corruption ethics |

**Progressive Reformers**

| Motivation | Examples |
|------------|----------|
| Democracy | Equality of voice |
| Anti-corporate | Reduce business influence |
| Public interest | Policy outcomes |
| Transparency | Open government |

### Business Reformers

**Companies Disadvantaged by System**

| Type | Reason for Support |
|------|-------------------|
| Non-lobbying companies | Level playing field |
| Small businesses | Can't compete |
| Ethical investors | ESG concerns |
| Tech disruptors | Challenge incumbents |

### Civic Organizations

**Potential Partners**

| Type | Interest |
|------|----------|
| Good government groups | Core mission |
| Faith communities | Ethical governance |
| Professional associations | Ethics standards |
| Academic institutions | Research, education |

### Affected Constituencies

**Groups with Stake**

| Group | Interest |
|-------|----------|
| Taxpayers | End corporate welfare |
| Healthcare consumers | Drug pricing |
| Environmental advocates | Climate policy |
| Labor unions | Worker interests |
| Veterans | VA lobbying issues |

## Key Relationships

### The Lobbying Triangle

```text

        Congress
         /    \
        /      \
Lobbyists --- Agencies

```text

**Dynamics**

| Relationship | Exchange |
|--------------|----------|
| Lobbyist-Congress | Money, information for access, influence |
| Lobbyist-Agency | Expertise for favorable rules |
| Congress-Agency | Oversight, funding for implementation |

### Coalition Dynamics

**Pro-Status Quo Coalition**

- K Street firms
- Major corporate lobbiers
- Benefiting politicians
- Trade associations
- Connected consultants

**Reform Coalition (Potential)**

- Good government groups
- Public interest organizations
- Reform-minded politicians
- Investigative journalists
- Civic organizations

## Related Topics

- [Opposition](06-opposition.md) - How beneficiaries resist reform
- [Solutions](07-solutions.md) - Addressing stakeholder interests
- [Campaign Finance: Stakeholders](../campaign-finance/05-stakeholders.md) - Overlapping interests
- [Congressional Reform: Stakeholders](../congressional-reform/05-stakeholders.md) - Institutional actors

## Document Navigation

- Previous: [Root Causes](04-root-causes.md)
- Next: [Opposition](06-opposition.md)
